{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"Sip Less. Weigh Less. Live Better. \ud83c\udf77\u2b07\ufe0f\u2696\ufe0f\u2728","description":"A fascinating Lancet RCT shows once-weekly semaglutide may redefine alcohol use disorder treatment. \ud83c\udfaf &amp;nbsp; In 108 adults with AUD and obesity, semaglutide reduced heavy drinking days by \u201313.7 percentage points vs placebo (p=0.0015) and improved craving, consumption, and biomarkers. \ud83d\udcc9 &amp;nbsp; With an NNT of ~4.3 and a manageable safety profile, GLP-1 therapy signals a shift from abstinence to precision harm reduction. \ud83d\udca1 &amp;nbsp; Efficacy. Safety. Meaningful impact. &amp;nbsp; Is this the beginning of a new era in addiction medicine? \ud83e\udde0\ud83d\udc89 ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41149735\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/201552630"}